National Research Council (U.S.). Committee on Ranking FDA Product Categories Based on Health Consequences, Phase II, & ebrary, Inc. (2011). Risk-characterization framework for decision-making at the food and drug administration. National Academies Press.
Copia nella clipboard completata con successo
Copia nella clipboard fallita
Citazione stile Chigago Style (17a edizione)
National Research Council (U.S.). Committee on Ranking FDA Product Categories Based on Health Consequences, Phase II, e Inc ebrary. Risk-characterization Framework for Decision-making at the Food and Drug Administration. Washington, DC: National Academies Press, 2011.
Copia nella clipboard completata con successo
Copia nella clipboard fallita
Citatione MLA (9a ed.)
National Research Council (U.S.). Committee on Ranking FDA Product Categories Based on Health Consequences, Phase II, e Inc ebrary. Risk-characterization Framework for Decision-making at the Food and Drug Administration. National Academies Press, 2011.
Copia nella clipboard completata con successo
Copia nella clipboard fallita
Attenzione: Queste citazioni potrebbero non essere precise al 100%.